PSCH 📈 Invesco S&P SmallCap - Overview

Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • ISIN: US46138E1495 • Health

PSCH: Healthcare, Pharmaceuticals, Biotechnology, Medical, Devices, Equipment

The fund generally will invest at least 90% of its total assets in the securities that comprise the index. Strictly in accordance with its guidelines and mandated procedures, S&P Dow Jones Indices, LLC compiles, maintains and calculates the index, which is designed to measure the performance of securities of small-capitalization U.S. companies in the health care sector, as defined by the Global Industry Classification Standard. ‣ Company URL: http://www.invesco.com/us ‣ Domicile: United States

Additional Sources for PSCH ETF

PSCH ETF Overview

Market Cap in USD 188m
Category Health
TER 0.29%
IPO / Inception 2010-04-07

PSCH ETF Ratings

Growth 5y 6.84%
Fundamental -
Dividend 22.7%
Rel. Strength Industry -87
Analysts -
Fair Price Momentum 40.76 USD
Fair Price DCF -

PSCH Dividends

Dividend Yield 12m 0.23%
Yield on Cost 5y 0.24%
Annual Growth 5y %
Payout Consistency 24.4%

PSCH Growth Ratios

Growth Correlation 3m 47.9%
Growth Correlation 12m 78%
Growth Correlation 5y -23.5%
CAGR 5y 1.13%
CAGR/Mean DD 5y 0.05
Sharpe Ratio 12m 0.16
Alpha -20.83
Beta 0.99
Volatility 23.61%
Current Volume 15.5k
Average Volume 20d 8.1k
What is the price of PSCH stocks?
As of December 29, 2024, the stock is trading at USD 45.13 with a total of 15,453 shares traded.
Over the past week, the price has changed by -0.05%, over one month by -6.12%, over three months by -1.06% and over the past year by +3.61%.
Is Invesco S&P SmallCap a good stock to buy?
Neither. Based on ValueRay Analyses, Invesco S&P SmallCap is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 6.84 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PSCH as of December 2024 is 40.76. This means that PSCH is currently overvalued and has a potential downside of -9.68%.
Is PSCH a buy, sell or hold?
Invesco S&P SmallCap has no consensus analysts rating.
What are the forecast for PSCH stock price target?
According to ValueRays Forecast Model, PSCH Invesco S&P SmallCap will be worth about 45.3 in December 2025. The stock is currently trading at 45.13. This means that the stock has a potential upside of +0.4%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 45.3 0.4%